Definium Therapeutics (DFTX) Prepaid Assets (2020 - 2026)
Definium Therapeutics (DFTX) reported Prepaid Assets of $7.1 million for Q1 2026, down 22.88% year-over-year from $9.3 million in Q1 2025, and down 7.58% quarter-over-quarter from $7.7 million in Q4 2025.
Definium Therapeutics (DFTX) Prepaid Assets (2020 - 2026) Analysis & Trends
Definium Therapeutics (DFTX) has 7 years of Prepaid Assets data on file, last reported at $7.1 million in Q1 2026.
- Prepaid Assets for Q1 2026 came in at $7.1 million, down 22.88% year-over-year; the trailing twelve-month figure through Mar 2026 was $7.1 million (down 22.88% YoY), and the FY2025 annual result was $7.7 million, down 1.93% from the prior year.
- Prepaid Assets fell to $7.1 million in Q1 2026 per DFTX's latest filing, from $7.7 million in the prior quarter.
- Over five years, Prepaid Assets peaked at $9.3 million in Q1 2025 and troughed at $1.8 million in Q3 2022.
- A 5-year average of $4.8 million and a median of $4.1 million in 2024 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2025 and 2026: Prepaid Assets jumped 194.97% in 2025, then fell 22.88% in 2026.
- A 5-year view of Prepaid Assets shows it stood at $3.9 million in 2022, then increased by 6.52% to $4.2 million in 2023, then jumped by 89.04% to $7.9 million in 2024, then slipped by 1.93% to $7.7 million in 2025, then declined by 7.58% to $7.1 million in 2026.
- Business Quant data shows DFTX's Prepaid Assets at $7.1 million in Q1 2026, $7.7 million in Q4 2025, and $6.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Definium Therapeutics | 2.46 Bn | 2.09 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.14 Mn |
| Dec 31, 2025 | 7.73 Mn |
| Sep 30, 2025 | 6.78 Mn |
| Jun 30, 2025 | 6.14 Mn |
| Mar 31, 2025 | 9.26 Mn |
| Dec 31, 2024 | 7.88 Mn |
| Sep 30, 2024 | 4.07 Mn |
| Jun 30, 2024 | 4.56 Mn |
| Mar 31, 2024 | 3.14 Mn |
| Dec 31, 2023 | 4.17 Mn |
| Sep 30, 2023 | 2.39 Mn |
| Jun 30, 2023 | 2.90 Mn |
| Mar 31, 2023 | 3.00 Mn |
| Dec 31, 2022 | 3.91 Mn |
| Sep 30, 2022 | 1.83 Mn |
| Jun 30, 2022 | 3.17 Mn |
| Mar 31, 2022 | 2.76 Mn |
| Dec 31, 2021 | 3.68 Mn |
| Dec 31, 2020 | 1.43 Mn |